A bitter pill to swallow: Slow growth, high expenses ail Raffles Med's prospects

Weak demand is hurting its bottom line.

High expenses and slowing regional healthcare demand are hurting Raffles Medical’s growth prospects, according to a report by CIMB.

CIMB said that the twin effects of dampened demand and higher costs were the key culprits behind the group’s sub-par results in the second quarter.

“We think that the more measured pace of economic growth in Singapore and the region, coupled with regional currencies weakening against the S$, will dampen healthcare demand. This was evident in 2Q15 when hospital services revenue rose by a modest 6.6% yoy, similar to the mid-single-digit growth in the past four quarters (vs. 13.7% average yoy growth in 2010-13),” the report noted.

“Even after accounting for the positives from its Shanghai hospital, we think its current valuations are not justified. The hospital extension has also been delayed from 1Q17 to 2Q17 due to construction issues. De-rating catalysts could come from slower than expected ramp up and further delays in expansion projects,” CIMB said.

Also Read

Singaporeans' physical well-being at highest level since 2019

SingHealth partners with OutcomesAI to integrate AI into medical workflows

Since you're here...

...there are many ways you can work with us to advertise your company and connect to your customers. Our team can help you dight and create an advertising campaign, in print and digital, on this website and in print magazine.

We can also organize a real life or digital event for you and find thought leader speakers as well as industry leaders, who could be your potential partners, to join the event. We also run some awards programmes which give you an opportunity to be recognized for your achievements during the year and you can join this as a participant or a sponsor.

Let us help you drive your business forward with a good partnership!

I want to download the media kit